A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH)

ZNA Jan Palfijn, Merksem

Antwerp University Hospital, Edegem

Imelda General Hospital, Bonheiden

UZ Leuven, Leuven

Az Damiaan vzw, Ostend

Centro Especializado En Diabetes, Obesidad Y Prevencion De Enfermedades Cardiovasculares, Mexico City

Medizinisches Versorgungszentrum am Bahnhof Spandau, Spandau

Diabeteszentrum Hamburg West, Hamburg

RED-Institut GmbH, Oldenburg in Holstein

Investigacion En Salud Y Metabolismo Sc, Chihuahua City

ALL Medical Research, LLC, Cooper City

Metabolic Research Institute, Inc., West Palm Beach

Diseno y Planeacion en Investigacion Medica, Guadalajara

Unidad de Investigación Clínica y Atención Médica HEPA, Guadalajara

InnoDiab Forschung Gmbh, Essen

Institut für Diabetesforschung GmbH Münster, Münster

Iowa Diabetes and Endocrinology Research Center, West Des Moines

NorthShore University Health System, Skokie

Instituto de Diabetes, Obesidad y Nutricion, Cuernavaca

"Hospital Universitario Dr. Jose Eleuterio Gonzalez", Monterrey

Unidad biomedica avanzada monterrey, Monterrey

Clinvest Research LLC, Springfield

"Hospital Universitario Dr. Jose Eleuterio Gonzalez", Monterrey

Alliance for Multispecialty Research, LLC, Norman

Southern Endocrinology Associates, Mesquite

North Hills Family Medicine/North Hills Medical Research, North Richland Hills

Juno Research, Houston

Biopharma Informatic, LLC, Houston

Juno Research, Houston

Centro de Estudios de Investigacion Metabolicos y Cardiovasculares, Ciudad Madero

Diabdana, Oradea

CMI DNBM Dr. Pop Lavinia, Baia Mare

Clinica Korall, Satu Mare

Mariodiab Clinic, Brasov

Gama Diamed, Mangalia

AZ Nikolaas, Sint-Niklaas

Studienzentrum Dr. Tasso Bieler, Riesa

Geea Medical Easy Diet, Bucharest